FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2FOR2240-Logo2
  • Home
  • About
  • Projects
    • P1 Lymph-Transplant
    • P2 Modulators of LA
    • N1 Ocular GvHD
    • N2 ABCB5 & Pterygium
    • P4 Ocular Melanoma
    • P5 Myeloid Cells
    • P6 Microglia in AMD
    • P8 Uveitis
    • C1 Eye Imaging
    • C2 Management
    • Publication highlights
  • Team
    • Executive Board
    • Research Groups
    • Central Projects
    • Associated projects
    • Alumni
  • Links
  • Events
    • Guest lectures
    • Retreats
    • Symposium
  • News
✕

Double triumph for cologne scientist.

Augenheilkunde, Cornea Lab Experimentelle Augenheilkunde

This year’s DOG Patent 2019 award went to Dr. Thomas Clahsen for his exceptional inventions in the area of ophthalmology. Dr. Clahsen is working at the University Hospital Cologne in the Department of Ophthalmology (Experimental Ophthalmology). This specific award is only given once a year and honors outstanding translational research and application for a patent in ophthalmology.

Dr. Thomas Clahsen is working on new Lymphangiogenesis modulators. He compared high-lymphangiogenesis C57BL/6 and low-lymphangiogenesis BALB/c mice with Quantitative Trait Locus analysis and found a new gen as a potential modulator of lymphangiogenesis. The patent describes the gen as a new useful therapeutic modulator of proliferation from lymphatic endothelial cells.

Dr. Clahsen further more was honored with the Best Paper Award for his presentation “Tyrosinase: How do pigments and angiogenesis in the eye correlate?”

Related posts

Claus Cursiefen

Claus Cursiefen

January 7, 2023

Rare eye diseases: Eight million euros for research: Funding for four years


Read more
December 15, 2022

Experimental Glaucoma Research Group awarded and funded


Read more
howald
November 17, 2020

Antonia Howaldt accepted into the Cologne Clinician Scientist Program


Read more

News

  • Rare eye diseases: Eight million euros for research: Funding for four years
  • Dr. Sarah Barbara Zwingelberg, is awarded Belmonte Fellowship for research on the neurobiology of the ocular surface
  • Experimental Glaucoma Research Group awarded and funded
  • Leonhard Klein-Preis for Prof. Matthaei
  • 4th Shanghai-Cologne Scientific Symposium

More information

  • Publication highlights
  • Jobs
  • Contact
  • Impressum
  • Datenschutz

Newest publications

Supplemental Anti Vegf A-Therapy Prevents Rebound…(2020)


Bevacizumab Induces Upregulation of Keratin 3 and VEGFA in Human…(2020)


Immune reactions after modern lamellar (DALK, DSAEK, DMEK) versus conventional…(2020)


Contact

Esther Engel
Management Office
DFG Research Unit FOR2240
Department of Ophthalmology
University of Cologne
Kerpener Str. 62
50937 Cologne, Germany

www.for2240.de

Tel. +49 (0)221 478 32845
Fax. +49 (0)221 478 5094
esther.engel@uk-koeln.de

Partnerlogos

© 2021 FOR2240 | Online Marketing von Resulted Lübeck